National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 4494-4495 [2019-02409]
Download as PDF
<![CDATA[
4494
Federal Register / Vol. 84, No. 32 / Friday, February 15, 2019 / Notices
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator—
Initiated Clinical Trial Planning Grant (R34).
Date: March 19, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Priti Mehrotra, Ph.D.,
Chief, Immunology Review Branch, Scientific
Review Program, Division of Extramural
Activities, Room #3G40, National Institutes
of Health/NIAID, 5601 Fishers Lane, MSC
9823, Bethesda, MD 20892–7616, 240–669–
5066, pmehrotra@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 11, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–02423 Filed 2–14–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKBBV9HB2PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
VerDate Sep<11>2014
19:41 Feb 14, 2019
Jkt 247001
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences National
Cancer Institute.
Date: July 8, 2019.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, Porter
Neuroscience Building, 35 Convent Drive,
Building 35 Bethesda, MD 20892.
Contact Person: Mehrdad M. Tondravi,
Ph.D., Chief, Institute Review Office, Office
of the Director, National Cancer Institute,
National Institutes of Health, 9609 Medical
Center, Room 3W302, Bethesda, MD 20892–
9750, 240–276–5664, tondravim@
mail.nih.gov.
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology National Cancer Institute.
Date: July 9, 2019.
Time: 9:00 a.m. to 3:45 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, Porter
Neuroscience Building, 35 Convent Drive,
Building 35 Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D.
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center, Room
3W414, Bethesda, MD 20892–9750, 240–276–
5664 wojcikb@mail.nih.gov.
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology National Cancer Institute.
Date: November 4, 2019.
Time: 9:00 a.m. to 3:45 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D.
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center, Room
3W414, Bethesda, MD 20892–9750, 240–276–
5664 ,wojcikb@mail.nih.gov.
Name of Committee: Board of Scientific
Counselors for Basic Sciences, National
Cancer Institute.
Date: November 5, 2019.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Mehrdad M. Tondravi,
Ph.D., Chief, Institute Review Office, Office
of the Director, National Cancer Institute,
National Institutes of Health, 9609 Medical
Center, Room 3W302, Bethesda, MD 20892–
9750, 240–276–5664, tondravim@
mail.nih.gov.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 11, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–02471 Filed 2–14–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Clinical and Basic Science Review
Committee.
Date: March 7–8, 2019.
Time: 10:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Crystal City, 1800
Jefferson Davis Highway, Alexandria, VA
22202.
Contact Person: Keith A. Mintzer, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7186, Bethesda, MD 20892–7924, 301–827–
7949, mintzerk@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
E:\FR\FM\15FEN1.SGM
15FEN1
Federal Register / Vol. 84, No. 32 / Friday, February 15, 2019 / Notices
Dated: February 11, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–02409 Filed 2–14–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meetings
khammond on DSKBBV9HB2PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the Office of AIDS Research
Advisory Council.
The meetings will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Office of AIDS
Research Advisory Council.
Date: March 28, 2019.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: The fiftieth meeting of the Office
of AIDS Research Advisory Council (OARAC)
will include the OAR Director’s Report;
updates from the DHHS HIV/AIDS Treatment
and Prevention Guidelines; updates from
HIV/AIDS Advisory Councils for NCI, NIDA,
NIMH and NIAD; the FY2021 NIH Plan for
HIV-Related Research; other HIV/AIDS
research activities across selected NIH
Institutes; and public comment.
Place: National Institutes of Health,
Conference Room 1D13, 5601 Fishers Lane,
Rockville, MD 20892.
Contact Person: Jay R. Radke, Ph.D.,
Scientific Review Officer, Office of AIDS
Research, National Institutes of Health, Ofc of
the Director, 5601 Fishers Lane, Room 2E61,
MSC–9834 Bethesda, MD 20892–9834, (240)
669–5046, jay.radke@nih.gov.
Name of Committee: Office of AIDS
Research Advisory Council.
Date: June 27, 2019.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: OAR Director’s Report; updates
from the DHHS HIV/AIDS Treatment and
Prevention Guidelines; updates from HIV/
AIDS Advisory Councils for NCI, NIDA,
NIMH and NIAD; the FY2021 NIH Plan for
HIV-Related Research; other HIV/AIDS
research activities across selected NIH
Institutes; and public comment.
Place: National Institutes of Health, 1D13,
5601 Fishers Lane, Rockville, MD 20852.
Contact Person: Jay R. Radke, Ph.D.,
Scientific Review Officer Office of AIDS
Research, National Institutes of Health, Ofc of
the Director, 5601 Fishers Lane, Room 2E61,
MSC–9834 Bethesda, MD 20892–9834, (240)
669–5046, jay.radke@nih.gov.
VerDate Sep<11>2014
19:41 Feb 14, 2019
Jkt 247001
Name of Committee: Office of AIDS
Research Advisory Council.
Date: November 7, 2019.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: OAR Director’s Report; updates
from the DHHS HIV/AIDS Treatment and
Prevention Guidelines; updates from HIV/
AIDS Advisory Councils for NCI, NIDA,
NIMH and NIAD; the FY2021 NIH Plan for
HIV-Related Research; other HIV/AIDS
research activities across selected NIH
Institutes; and public comment.
Place: National Institutes of Health, 1D13,
5601 Fishers Lane, Rockville, MD 20852.
Contact Person: Jay R. Radke, Ph.D.,
Scientific Review Officer, Office of AIDS
Research, National Institutes of Health, Ofc of
the Director, 5601 Fishers Lane, Room 2E61,
MSC–9834 Bethesda, MD 20892–9834, (240)
669–5046, jay.radke@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.oar.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
4495
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: NIDCR Special Grants
Review Committee.
Date: June 13–14, 2019.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westgate Hotel, 1055 2nd Ave.,
San Diego, CA 92101.
Contact Person: Latarsha J. Carithers,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of Dental
and Craniofacial, Bethesda, MD 20892, 301–
594–4859, latarsha.carithers@nih.gov.
Name of Committee: NIDCR Special Grants
Review Committee.
Date: October 17–18, 2019.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westgate Hotel, 1055 Second
Avenue, San Diego, CA 92101.
Contact Person: Latarsha J. Carithers,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of Dental
and Craniofacial, Bethesda, MD 20892, 301–
594–4859, latarsha.carithers@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: February 11, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–02428 Filed 2–14–19; 8:45 am]
BILLING CODE 4140–01–P
Dated: February 11, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–02432 Filed 2–14–19; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
Center for Scientific Review; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
National Institutes of Health
National Institute of Dental &
Craniofacial Research Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\15FEN1.SGM
15FEN1
]]>Agencies
[Federal Register Volume 84, Number 32 (Friday, February 15, 2019)]
[Notices]
[Pages 4494-4495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02409]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group;
NHLBI Mentored Clinical and Basic Science Review Committee.
Date: March 7-8, 2019.
Time: 10:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Westin Crystal City, 1800 Jefferson Davis Highway,
Alexandria, VA 22202.
Contact Person: Keith A. Mintzer, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7186, Bethesda, MD
20892-7924, 301-827-7949, mintzerk@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
[[Page 4495]]
Dated: February 11, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-02409 Filed 2-14-19; 8:45 am]
BILLING CODE 4140-01-P
